Stage IIIC Prostate Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for Luteinizing hormone (DB14741)

IndicationStatusPhase
DBCOND0109672 (Stage IIIC Prostate Cancer AJCC v8)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04037254Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate CancerTreatment
NCT03279250Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate CancerTreatment